Alliance Pharma's market cap is currently ―. The company's EPS TTM is p-0.013; its P/E ratio is -30.79; and it has a dividend yield of 4.82%. Alliance Pharma is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is p0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 31.71M	£ 29.38M	£ 29.06M	£ 27.39M	£ 28.90M
Total Assets	£ 537.41M	£ 548.57M	£ 503.49M	£ 513.96M	£ 508.85M
Total Debt	£ 137.58M	£ 136.24M	£ 118.94M	£ 136.49M	£ 142.02M
Net Debt	£ 105.86M	£ 106.86M	£ 89.88M	£ 109.10M	£ 113.13M
Total Liabilities	£ 249.75M	£ 251.64M	£ 221.00M	£ 233.79M	£ 227.90M
Stockholders Equity	£ 287.66M	£ 296.93M	£ 282.49M	£ 280.17M	£ 280.96M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

Alliance Pharma Earnings and Revenue History

Income Statement >

Alliance Pharma Debt to Assets

Balance Sheet >

Alliance Pharma Cash Flow

Cash Flow >

Alliance Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing